Bibliografia

1. Lin GC, Erinoff L. Anabolic steroid abuse. US department of health and human services public health service, National institutes on drug abuse monograph series 1990; 102: 97-112.

2. Office of diversion control. Report of the international conference on the abuse and trafficking of anabolic steroids. US drug enforcement administration conference report. Washington DC, 1994.

3. Yesalis CE, Kennedy NJ, Kopstein AN et al. Anabolic-androgenic steroid use in the United States. JAMA 1993; 270: 1217-21.

4. Catlin DH, Halton CK. Use and abuse of anabolics and other drugs for athletic enhancement. Adv Intern Med 1991; 36: 399-424.

5. Terney R, McLain L. The use of anabolic steroids in high school students. Am J Dis Child 1990; 144: 99-103.

6. Matava MJ. Anabolic steroids and the athlete. Sports Medicine Update 2002; 1: 4-8.

7. Sader MA, Griffiths KA, McCredie RJ et al. Androgenic anabolic steroids and arterial structure and function in male bodybuilders. J Am Coll Cardiol 2001; 37: 224-30.

8. Karila T. Adverse effects of anabolic androgenic steroids on the cardiovascular, metabolic and reproductive systems of anabolic substance abusers. Thesis to the University of Helsinki 2003. Helsinki, Finland.

9. Basaria S, Wahlstrom JT, Dobs AS. Clinical review Anabolic-androgenic steroid therapy in the treatment of chronic diseases. J Clin Endocrinol Metab 2001; 86: 5108-17.

10. Elliot D, Goldberg L. Intervention and prevention of steroid use in adolescents. Am J Sports Med 1996; 24: 46-7.

11. Bhasin S, Woodhouse L, Casaburi R et al. Testosterone dose-response relationship in healthy young men. Am J Physiol Endocrinol Metab 2001; 81: 1172-81.

12. Soory M. Targets for steroid hormone mediated actions of periodontal pathogens, cytokines and therapeutic agents: some implications on tissue turnover in the periodontium. Curr Drug Targets 2000; 1: 309-25.

13. Soory M, Tilakaratne A. Anabolic potential of fibroblasts from chronically inflamed gingiva grown in a hyperglycemic culture medium in the presence or absence of insulin and nicotine. J Periodontol 2003; 74: 1771-77.

14. Soory M, Kasasa SC. The effects of epidermal growth factor, interleukin-1 and phenytoin, alone and in combination on C19 steroid conversions in fibroblasts. J Periodontol 1997; 68: 819-26.

15. Soory M, Virdi H. The uptake of two androgen substrates by cultured human gingival fibroblasts in response to minocycline and metabolic studies using a cell-free system. Arch Oral Biol 1999; 44: 215-22.

16. Kasperk CH, Wergedal JE, Farley JR et al. Androgens directly stimulate proliferation of bone cells in vitro. Endocrinol 1989; 124: 1576-8.

17. Parkar MH, Newman HN, Olsen I. Polymerase chain reaction analysis of oestrogen and androgen receptor expression in human gingival and periodontal tissue. Arch Oral Biol 1996; 41: 979-83.

18. Genco RJ. Current view of risk factors for periodontal disease. J Periodontol 1996; 67: 1041-9.

19. Scannapieco FA. Position paper of the American academy of periodontology: periodontal disease as a risk factor for systemic diseases. J Periodontol 1998; 69: 841-50.

20. Haytac MC, Cetin T, Seydaoglu G. The effects of ovulation induction during infertility treatment on gingival inflammation. J Periodontol 2004; 75: 805-10.

21. Abnet CC, Kamangar F, Dawsey SM et al. Tooth loss is associated with increased risk of gastric non-cardia adenocarcinoma in a cohort of Finnish smokers. Scand J Gastroenterol 2005; 40: 681-7.

22. Lopez NJ, Smith PC, Gutierrez J. Higher risk of preterm birth and low birth weight in women with periodontal disease. J Dent Res 2002; 81: 58-63.

23. Joshipural KJ, Rimm EB, Douglass CW et al. Poor oral health and coronary heart disease. J Dent Res 1996; 75: 1631-6.

24. Tilakaratne A, Soory M. Modulation of androgen metabolism by estradiol-17 ß and progesterone, alone and in combination, in human gingival fibroblasts in culture. J Periodontol 1999; 70: 1017-25.

25. Coletta RD, Reynolds MA, Martelli-Junior H et al. Testosterone stimulates proliferation and inhibits interleukin-6 production of normal and hereditary gingival fibromatosis fibroblasts. Oral Microbiol Immunol 2002; 17: 186-92.

26. Kasasa SC, Soory M. The synthesis of 5 a -dihydro-testosterone from androgens by human gingival tissues and fibroblasts in culture in response to TGF- ß and PDGF. J Periodont Res 1996; 31: 312-21.

27. Vittek J, Rappaport SC, Gordon GG et al. Concentration of circulating hormones and metabolism of androgens by human gingiva. J Periodontol 1979; 50: 254-64.

28. Parkar M, Tabona P, Newman H et al. IL-6 expression by oral fibroblasts is regulated by androgen. Cytokine 1998; 10: 613-9.

29. Gornstein RA, Lapp CA, Bustos-Valdes SM et al. Androgens modulate interleukin-6 production by gingival fibroblasts in vitro. J Periodontol 1999; 70: 604-9.

30. Ozcelik O, Haytac MC, Seydaoglu G. The effects of anabolic androgenic steroid abuse on gingival tissues. J Periodontol 2006; 77: 1104-9.

31. Pope HG, Katz DL. Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes. Arch Gen Psychiatry 1994; 51: 375-82.

32. Pope HG Jr, Kouri EM, Hudson MD. Effects of supraphysiologic doses of testosterone on mood and aggression in normal men. Arch Gen Psychiatry 2000; 57: 133-40.

33. Genco RJ, Ho AW, Grossi SG et al. Relationship of stress, distress and inadequate coping behaviors to periodontal disease. J Periodontol 1999; 70: 711-23.